
Daniel Alejandro Mazal
Radiology/CT Scans
42+
Years of Experience
About Daniel Alejandro Mazal
<h3><strong>Professional Resume</strong></h3><h4> <strong>Basic education</strong></h4><ul><li> <strong>Electronic Engineering</strong> , Buenos Aires (1984)</li><li> <strong>Physics of Radiotherapy</strong> , National Atomic Energy Commission of Argentina (CNEA, 1984)</li><li> <strong>Master of Medical Physics</strong> , Universities of Toulouse and Paris (1986)</li><li> <strong>Doctor of Science in Medical Physics</strong> , Universities of Toulouse and Paris (1990, Stereotactic Radiotherapy)</li></ul><h4> <strong>Publications</strong></h4><ul><li> <strong>Scientific index:</strong> 36.93</li><li> <strong>Number of publications:</strong> 140</li></ul><h3> <strong>Professional activity</strong></h3><ul><li> <strong>1980-1984</strong> – Lecturer, University of Buenos Aires</li><li> <strong>1982-1984</strong> – Academy of National Medicine of Argentina</li><li> <strong>1985-2018</strong> – Institut Curie (Paris)<ul><li> <strong>Latest positions:</strong><ul><li> Technical Director of the Proton Therapy Center</li><li> Head of the Department of Medical Physics</li></ul></li></ul></li></ul><h3> <strong>Research Internships as a Visiting Professor</strong></h3><ul><li> <strong>2003-2004</strong> – Massachusetts General Hospital & Harvard Medical School (Boston, USA)</li><li> <strong>1998</strong> – Indiana University Cyclotron Facility (Bloomington, USA)</li></ul><h3> <strong>Membership in scientific committees</strong></h3><ul><li> <strong>2014</strong> – CERN International Strategy Committee for Medical Applications</li><li> <strong>2000</strong> – Conseil Scientifique National de Hadrontherapie (France)</li><li> <strong>2012</strong> – The Belgian Hadrontherapy Center Foundation</li><li> Scientific and expert consultant for companies: <strong>IBA, IBA Dosimetry, Varian Particles, Siemens, Tomotherapy</strong></li><li> Scientific advisor at proton therapy centers in various countries:<ul><li> China (Wanjie)</li><li> South Africa (Cape Town)</li><li> USA (Indiana, New York)</li><li> Italy (Trento)</li><li> South Korea (Seoul)</li><li> France (Caen)</li><li> Netherlands (Maastro)</li><li> Argentina (Buenos Aires)</li><li> Austria (MedAustron)</li></ul></li><li> Member of the Scientific Council at the Embassy of Argentina in France</li></ul><h3> <strong>Reviewing articles for scientific journals</strong></h3><ul><li> Physics in Medicine and Biology</li><li> Medical Physics</li><li> Physics Medicine</li><li> Radiotherapy and Oncology</li><li> Radiation Protection Dosimetry</li><li> Radioprotection</li><li> Cureus and others</li></ul><h3> <strong>Membership in scientific societies</strong></h3><ul><li> <strong>PTCOG</strong> (Particle Therapy Cooperative Group) – Chairman (2010-2013)</li><li> <strong>ESTRO</strong> (European Society for Radiotherapy and Oncology)</li><li> <strong>SFPM</strong> (Société Française de Physique Médicale)</li><li> <strong>PMSF</strong> (Physiciens Médicaux Sans Frontières)</li></ul><h3> <strong>Teaching activities</strong></h3><ul><li> <strong>Master's program "Medical Physics"</strong> , Faculty of Medicine, University of Paris-Sud</li><li> <strong>School of Proton Therapy ESTRO</strong></li><li> <strong>PTCOG Educational Master Classes</strong></li><li> <strong>Inter-University Diploma in High-Tech Radiotherapy</strong></li><li> <strong>Diploma in Radiation Biology and Radiation Protection in Radiotherapy (France)</strong></li><li> <strong>AAPM Summer School</strong> , Colorado Springs, USA (2015)</li><li> <strong>Scientific supervision of postgraduate students, masters students, interns (up to 10 students per year)</strong></li><li> <strong>Invited lectures in various countries around the world (about 10 per year)</strong></li></ul><h3> <strong>Grants and funding received (more than €50 million)</strong></h3><ol><li> <strong>MIGAC</strong> – New Proton Therapy Centre of the Institut Curie</li><li> <strong>Grant Canceropole</strong><ul><li> <strong>(a)</strong> Targeted proton therapy for pediatric and adult tumors: technical optimization, radiobiology, socioeconomic assessment</li><li> <strong>(b)</strong> Dynamic proton therapy</li></ul></li><li> <strong>Grant Physician</strong> – DEDIPRO (development of a new diamond detector and fast radiation therapy planning system for pulsed proton beams)</li><li> <strong>Industrial and regional grants</strong> – Areva 1-2-3, Feder, Varian, etc.</li><li> <strong>European Commission Grants</strong><ul><li> <strong>INFRAIA-02-2017</strong> – INSPIRE (Infrastructure for International Proton Therapy Research)</li></ul></li><li> <strong>IDEX Paris-Saclay</strong> – NanoTheRad (research on nanoparticles in medicine)</li></ol><p> This specialist has made significant contributions to the development of proton therapy, radiation oncology and medical physics, combining scientific research, teaching and work at the world's leading medical and research institutions.</p><p></p><p></p><p></p><p></p>
Good to know
Speciality
• Radiology/CT Scans
Language Spoken
• English• Spanish
Awards
- • Former Chairman of the Particle Therapy Cooperative Group (PTCOG)
- • Member of the CERN International Strategy Committee for Medical Applications
- • Member of the European Society for Radiotherapy and Oncology (ESTRO)
- • Member of the Belgian Hadrontherapy Center Foundation
- • Member of the Scientific Council at the Embassy of Argentina in France
- • Member of the Société Française de Physique Médicale (SFPM)
- • Member of the Physiciens Médicaux Sans Frontières (PMSF)
Nuclear medicine physician
1985–2018 – Technical Director of the Proton Therapy Center and Head of Medical Physics, Institut Curie, Paris
1982–1984 – Academy of National Medicine of Argentina
1980–1984 – Lecturer, University of Buenos Aires
Scientific and expert consultant for IBA, IBA Dosimetry, Varian Particles, Siemens, and Tomotherapy
All Procedures
Performed by Daniel Alejandro Mazal
All Procedures Performed by Daniel Alejandro Mazal
CureMeAbroadIs Absolutely Free
Just discovery so you can choose what's right for you!


World's No. 1 Medical Discovery Platform

